They found that both aPS/PT IgG (OR 2.72, 95%CI: 1.75–4.24) and aPS/PT IgM (OR 2.81, 1.83–4.32) were significantly correlated with clinical symptoms of APS. The gene discussed is CD40LG; the disease is autoimmune polyendocrinopathy.